Simeon George, Director at Turning Point Therapeutics, Inc. (TPTX), bought 177,777 shares at $45.00 ($8.0M) on 2019-09-10, disclosed to the SEC on 2019-09-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| DSGN | BUY | 2022-12-20 | $14.8M | — | Filing → |
| NKTX | BUY | 2022-04-29 | $20.0M | — | Filing → |
| DSGN | BUY | 2021-04-01 | $5.0M | — | Filing → |